Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AorTech hits more trouble, continues strategy review

This article was originally published in Clinica

Executive Summary

Little has gone right this year for AorTech International, but this week the words "company break up" were mentioned in the press for the first time in the wake of a warning from the Bellshill, Scotland company that it would record lower sales and an increased loss in the current half year. Sales would be some 45% lower, at £1.1m ($1.7m) in the six months to September 30 2002, and the loss would rise by 40% to some £7m. The ongoing strategy review will continue over the coming weeks, focusing on manufacturing, said a spokesman.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts